IP Library Granted Patent US 9,988,640
Granted Patent B2
US 9,988,640 · App. 14/681,073 · Granted Jun 5, 2018

Nucleic acid sequences encoding transcription factors regulating alkaloid biosynthesis and their use in modifying plant metabolism

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,988,640
App. No.
14/681,073
Granted
Jun 5, 2018
Kind
B2
Abstract

Plant metabolism and alkaloid levels can be regulated by transcription factors that regulate the nicotinic alkaloid biosynthetic pathway. In one embodiment, the disclosure provides a transcription factor that negatively regulates alkaloid biosynthesis, such as nicotine biosynthesis.

Claims (17)

1. A genetically engineered, reduced nicotinic alkaloid-producing Nicotiana plant comprising reduced expression of a NbTF5 transcription factor as compared to a control plant, wherein the amino acid sequence of said NbTF5 transcription factor is set forth in SEQ ID NO: 10, wherein the Nicotiana plant comprises a recombinant nucleic acid construct selected from the group consisting of:

(a) a polynucleotide sequence in sense orientation or antisense orientation that suppresses expression of the transcription factor, and

(b) a short interfering RNA molecule comprising a polynucleotide sequence that suppresses expression of the transcription factor,

wherein the polynucleotide sequence of (a) and (b) comprises at least 21 consecutive nucleotides of a sequence selected from the group consisting of:

(i) the nucleotide sequence set forth in SEQ ID NO: 8 or SEQ ID NO: 9; and

(ii) a nucleotide sequence that encodes a polypeptide having the amino acid sequence set forth in SEQ ID NO: 10;

wherein the polynucleotide sequence in (a) and (b) is operably linked to one or more heterologous sequences.

2. The genetically engineered plant of claim 1 , wherein the plant is a decreased-nicotinic alkaloid Nicotiana tabacum plant.

3. The genetically engineered Nicotiana plant of claim 1 , wherein the recombinant nucleic acid construct further comprises one or more of the NBB1, A622, quinolate phospho-ribosyltransferase (QPT), putrescine-N-methyltransferase (PMT) and N-methylputrescine oxidase (MPO) genes, wherein the expression of the one or more genes is suppressed as compared to a control plant.

4. Seeds from the genetically engineered Nicotiana plant of claim 1 , wherein the seeds comprise the recombinant nucleic acid construct.

5. A product having a reduced level of a nicotinic alkaloid comprising the genetically engineered Nicotiana plant of claim 1 , or portions thereof.

6. The product of claim 5 , wherein the tobacco product is selected from the group consisting of a reduced-nicotine cigarette, a cigarette, cigarette tobacco, cigar tobacco, a cigar, pipe tobacco, chewing tobacco, snuff, snus, and reconstituted tobacco.

7. A method of producing the genetically engineered reduced nicotinic alkaloid-producing Nicotiana plant of claim 1 , wherein the method of reducing the nicotinic alkaloid comprises down-regulating the NbTF5 transcription factor, wherein the transcription factor is down-regulated by:

a) introducing into the Nicotiana plant a nucleotide sequence comprising at least 21 consecutive nucleotides of a sequence selected from the group consisting of SEQ ID NO: 8, SEQ ID NO; 9, and a sequence that encodes the amino acid sequence set forth in SEQ ID NO: 10, wherein the consecutive nucleotides are in either sense or antisense orientation; and

(b) growing the Nicotiana plant under conditions whereby the introduced nucleotide sequence decreases levels of the transcription factor in the plant as compared to a control plant grown under similar conditions.

8. A method of producing the genetically engineered reduced nicotinic alkaloid-producing Nicotiana plant of claim 1 , wherein the method of reducing the nicotinic alkaloid comprises down-regulating the NbTF5 transcription factor, wherein the NbTF5 transcription factor is down-regulated by introducing into a plant cell of the Nicotiana plant a nucleic acid construct that expresses the short interfering RNA molecule of claim 1 that suppresses expression of a gene product encoded by SEQ ID NO: 8 or SEQ ID NO: 9.

9. A method of producing the genetically engineered reduced nicotinic alkaloid-producing Nicotiana plant of claim 1 , wherein the method of reducing the nicotinic alkaloid comprises down-regulating the NbTF5 transcription factor, wherein the NbTF5 transcription factor is down-regulated by introducing into a plant cell of the Nicotiana plant a nucleic acid construct comprising, in the 5′ to 3′ direction, (a) a promoter operably linked to a heterologous nucleic acid encoding SEQ ID NO: 10 in the sense or antisense orientation, and (b) a terminator.

Assignments (2)
PATENT SECURITY AGREEMENT Recorded Mar 29, 2023
From: 22ND CENTURY GROUP, INC.
To: JGB COLLATERAL, LLC
Reel/Frame 063188/0812 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 19, 2021
From: NATIONAL RESEARCH COUNCIL OF CANADA
To: 22ND CENTURY LIMITED, LLC
Reel/Frame 055660/0188 →